Clinical Trials Update: June 2, 2006
Generalized Anxiety Disorder (GAD) Insomnia Stomach Discomfort
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Generalized Anxiety Disorder (GAD)
This is a 10-week study to evaluate the safety and efficacy of an investigational drug to treat generalized anxiety disorder. Volunteers 18 to 65 with a documented clinical diagnosis of generalized anxiety disorder who do not have a current or past diagnosis of stroke or transient ischemic attack (TIA) may be included.
The research sites are located throughout the United States.
This study will evaluate an investigational combination of two approved medications to treat chronic insomnia. Candidates 18 to 80 who have had trouble falling asleep or staying asleep for at least three months and are in good general health may be eligible. The study will consist of two daytime office visits and four overnight stays during a one-month period.
Research sites are located throughout the United States.
This is a clinical research study of an investigational medication to treat abdominal pain. Volunteers may qualify who are 18 and older and have abdominal pain or discomfort that occurs at least twice a month (but not daily) and is bothersome enough to require treatment.
The research site is in San Antonio, Texas.
Copyright 2006 CenterWatch. All rights reserved.